UroGen Pharma Ltd Cash Flow Quality Index

Latest as of December 2016: 1.03x

UroGen Pharma Ltd cash flow quality index. UroGen Pharma Ltd (URGN) has a Cash Flow Quality Index of 1.03x as of December 2016. Operating cash flow of $13.35 Million exceeds net income of $12.92 Million, indicating high earnings quality where cash backs reported profits. See URGN financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

1.03x

Operating CF / Net Income

Operating Cash Flow

$13.35 Million

USD

Net Income

$12.92 Million

USD

Data as of

Dec 2016

Most recent filing

UroGen Pharma Ltd Cash Flow Quality Index by Year (None–None)

UroGen Pharma Ltd cash flow quality index by year from None to None. Year-by-year earnings quality comparison for UroGen Pharma Ltd. For the full cash flow conversion analysis, see how efficiently does UroGen Pharma Ltd generate cash.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.